Data coverage, completeness and provenance for NEXALIS THERAPEUTICS LTD in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-27T23:49:53. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0090 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/NX1/prices · Price parameters and adjustment semantics
Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. The company develops IRX-211 for the management of breakthrough cancer pain and IRX-616a for the treatment of panic disorder, which are inhaled medications delivered through a pressurized metered dose inhaler. It also develops SRX-25 for treatment resistant depression. The company was formerly known as InhaleRx Limited and changed its name to Nexalis Therapeutics Limited in January 2026. Nexalis Therapeutics Limited was incorporated in 2016 and is based in Melbourne, Australia.
Website: https://inhalerx.com.au · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2025), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/NX1/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (AUD) | 2025-12-31 | 22 | yfinance | ||||
| FY2024 (AUD) | 2024-12-31 | 21 | yfinance | ||||
| FY2023 (AUD) | 2023-12-31 | 20 | yfinance | ||||
| FY2022 (AUD) | 2022-12-31 | 25 | yfinance | ||||
| FY2021 (AUD) | 2021-12-31 | 9 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/NX1
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/NX1/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/NX1/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/NX1/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/NX1/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/NX1
Free tier — instant API key. Built for AI agents.